Expired activity
Please go to the PowerPak homepage and select a course.

Meeting Managed Care's Challenge to Identify and Manage Narcolepsy – The Narcolepsy Managed Care Tool Kit

This activity is jointly provided by Postgraduate Institute for Medicine and Impact Education, LLC.

This activity is supported by an independent educational grant from Jazz Pharmaceuticals, Inc.


December 1, 2016


June 1, 2018

Estimated time to complete activity

1.0 hour


This activity is intended for managed care-affiliated pharmacists engaged in the care of patients with narcolepsy.


Narcolepsy is a chronic, incurable, and potentially disabling neurologic disorder that is primarily characterized by excessive sleepiness (EDS) and signs of rapid eye movement (REM) sleep dissociation, such as cataplexy.  The clinical, psychosocial, and socioeconomic consequences of poor sleep quality and EDS can be severe, with variable and potentially devastating manifestations that range from cardiovascular events and psychiatric comorbidities to poor occupational performance and motor vehicle accidents. This activity will provide instruction on current treatment strategies, medical and pharmacy benefit management, and patient care strategies for managed care professionals to improve overall health and economic outcomes for patients with narcolepsy.


Upon completion of this activity, participants should be better able to:

  1. Evaluate current pharmacologic treatments for narcolepsy based on available efficacy, safety, and cost data
  2. Implement plan-wide initiatives to better coordinate care for narcolepsy among primary care physicians, sleep specialists, and ancillary providers
  3. Incorporate value-driven assessment approaches for member drug benefit design and appropriate formulary positioning of narcolepsy therapies
  4. Provide accurate and appropriate counsel as part of the managed care treatment team
  5. Provide appropriate care and counsel for patients and their families


Jeffrey Dunn, PharmD, MBA Jeffrey Dunn, PharmD, MBA
Senior Vice President
Chief Clinical Officer
VRx Pharmacy Services, LLC
John Knispel, MD, CPE, FACOG John Knispel, MD, CPE, FACOG
Regional Medical Director
Florida Commercial Markets
Health Guidance Organization
Humana, Inc.
Phyllis C. Zee, MD, PhD Phyllis C. Zee, MD, PhD
Director, Center for Circadian and Sleep Medicine
Professor of Neurology
Northwestern University Feinberg School of Medicine


Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.


Name of Faculty or Presenter Reported Financial Relationship
Jeffrey Dunn, PharmD, MBA No financial interest/relationships relating to the topic of this activity
John Knispel, MD, CPE, FACOG Consulting Fees: Xcenda, Amgen, Vita Med MD
Phyllis C. Zee, MD, PhD Consulting Fees: Philips, Merck, Eisai
Contracted Research: Jazz, Eisai, Philips, Technogel
Ownership Interest (stocks, stock options, or other ownership interest excluding diversified mutual funds): Teva

Planners and Managers
The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose. The Impact Education, LLC planners and managers have nothing to disclose.


acpeContinuing Pharmacy Education
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number: 0809-9999-16-531-H01-P)

Type of Activity: Application 

Media: Internet

Fee Information: There is no fee for this educational activity.


During the period December 1, 2016 through June 1, 2018, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the posttest and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on Submit Posttest at the bottom of the page. Your posttest will automatically be graded. If you successfully complete the posttest (score of 75% or higher), your Statement of Participation will be made available immediately. Click on the View Statement of Participation and print the statement for your records. If you receive a score lower than 75%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest. To receive Credit, you must provide your date of birth and NABP number.  All Credit information will be uploaded into CPE monitor within 30 days.

If you have any questions relating to the certification of this activity, please contact Postgraduate Institute for Medicine via www.pimed.com.

Disclosure of Unlabeled Use and Disclaimer

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.


Please ensure the computer system you plan to use meets the following minimum requirements:

  • Operating System: Windows 98 or higher & Macintosh 2.2 or higher
  • Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
  • Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
  • Peripherals: Computer speakers or headphones
  • Monitor Screen Resolution: 320 x 480 or higher
  • Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5